Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Hamas hands over another body in the Gaza Strip - 2Tesla Germany Registrations Quadruple to 9,252 Vehicles in Best March Ever
- 3Figure out How to Utilize Your Web based Advertising Degree to Break into the Tech Business
- 4Best Getaway destination: Ocean side, Mountain, or City
- 5Why don’t humans have hair all over their bodies? A biologist explains our lack of fur
- First foreign troop in new gang suppression force lands in Haiti to replace previous mission
- A 'Stranger Things' documentary covering the final season is on its way: Watch the trailer
- Figure out How to Get the Most Familiar Drive for Seniors in SUVs
- Woman shocked to welcome baby after experiencing stomach pain on Christmas
- Israel’s mixed messaging on Christmas draws controversy
- Vote in favor of Your #1 Instructive Toy: Learning and Tomfoolery Joined
- Top 20 Wellbeing and Wellness Applications for a Sound Way of life
- RFK Jr. releases new dietary guidelines with emphasis on protein, full-fat dairy
- CDC advisory panel delays vote on hepatitis B vaccines after unruly meeting
